Business Context and Reporting Period
This Form 6-K filing by Therapix Biosciences Ltd. (not Scisparc Ltd.) covers the month of December 2020, specifically dated December 15, 2020. The report discloses a material corporate governance event regarding the resignation of a board member.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a personnel change and does not contain financial statements or performance data.
Material Changes
On December 15, 2020, Mr. Lior Amit tendered his resignation from the Board of Directors, effective immediately. The Company stated that the resignation is due to personal reasons and is not related to any disagreements or Company-related issues.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. No specific risks or contingencies were disclosed beyond the standard incorporation by reference into existing registration statements (Forms F-3 and S-8).
Key Facts for Investor Verification
- Mr. Lior Amit resigned from the Board of Directors effective December 15, 2020.
- The resignation was attributed to personal reasons with no stated disagreement with the Company.
- The filing is signed by Oz Adler, Chief Financial Officer.
- No financial performance data is included in this specific report.